CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Regadenoson myocardial perfusion imaging stress testWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (5)

Name (Synonyms) Correlation
drug2559 Treadmill electrocardiographic stress test Wiki 1.00
drug668 Coronary artery calcium score and cardiac computed tomographic angiography Wiki 1.00
drug211 Arm exercise electrocardiographic stress test Wiki 1.00
drug2069 Remestemcel-L Wiki 0.58
drug1822 Placebo Wiki 0.06

Correlated MeSH Terms (4)

Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Arm Exercise Versus Pharmacologic Stress Testing for Clinical Outcome Prediction

This is a 5-year clinical trial to evaluate whether arm exercise electrocardiographic (ECG) stress testing without or with coronary artery calcium scoring (-/+ CAC) is non-inferior to treadmill ECG stress testing -/+ CAC and pharmacologic myocardial perfusion imaging as an initial evaluation to detect obstructive coronary artery disease, determined by cardiac computed tomographic angiography (CTA) and to predict clinical outcome, defined by a primary clinical endpoint of the composite of cardiovascular (CV) mortality, myocardial infarction, and 90-day post-stress test coronary artery revascularization and secondary clinical endpoints of all-cause mortality and CV mortality.

NCT03449888 Veterans Referred to the St. Louis VAMC Stress Tes Procedure: Regadenoson myocardial perfusion imaging stress test Procedure: Arm exercise electrocardiographic stress test Procedure: Treadmill electrocardiographic stress test Procedure: Coronary artery calcium score and cardiac computed tomographic angiography

Primary Outcomes

Description: Death from a cardiovascular cause, occurrence of myocardial infarction, and 90-day post-stress test coronary artery revascularization by any technique determined from VA, National Death Index, Missouri Health and Human Services, and non-VA medical records, and patient follow-up information.

Measure: Composite of cardiovascular mortality, myocardial infarction, and 90-day post-stress test coronary artery revascularization

Time: 5 years

Secondary Outcomes

Description: Death from any cause determined from VA, Social Security, and National Death Index records and patient follow-up information.

Measure: All-cause mortality

Time: 5 years

Description: Death from a cardiovascular cause determined from VA, Missouri Health and Human Services, and National Death Index records and patient follow-up information.

Measure: Cardiovascular mortality

Time: 5 years

Other Outcomes

Description: Severely (at least 70%) or completely occluded epicardial coronary arteries or grafts determined by cardiac computed tomographic angiography or invasive coronary arteriography

Measure: Obstructive coronary artery disease

Time: 5 years

No related HPO nodes (Using clinical trials)